Andere Kunden interessierten sich auch für
![Computational Epitopes-Based Vaccine against Sin Nombre Virus]( "Computational Epitopes-Based Vaccine against Sin Nombre Virus")
Computational Epitopes-Based Vaccine against Sin Nombre Virus19,99 €![Computational Epitopes-Based Vaccine gegen Sin Nombre Virus]( "Computational Epitopes-Based Vaccine gegen Sin Nombre Virus")
Computational Epitopes-Based Vaccine gegen Sin Nombre Virus39,90 €![Computational Epitopes-Based Vaccine against Sin Nombre Virus]( "Computational Epitopes-Based Vaccine against Sin Nombre Virus")
Computational Epitopes-Based Vaccine against Sin Nombre Virus23,99 €![Dynamics-based Computational Design of Anti-Cancer Drugs]( "Dynamics-based Computational Design of Anti-Cancer Drugs")
Dynamics-based Computational Design of Anti-Cancer Drugs32,99 €![Forthcoming Selective CDKs Inhibitors as Anti-cancer Drugs]( "Forthcoming Selective CDKs Inhibitors as Anti-cancer Drugs")
Forthcoming Selective CDKs Inhibitors as Anti-cancer Drugs23,99 €![Human nasal primary cell cultures for peptide delivery studies]( "Human nasal primary cell cultures for peptide delivery studies")
Human nasal primary cell cultures for peptide delivery studies36,99 €![Next Generation Bioprocessing]( "Next Generation Bioprocessing")
Next Generation Bioprocessing60,99 €
Merkel cell carcinoma is an aggressive highly metastatic skin cancer. Developing an advanced vaccine for MCC that specifically targets the immunogenic proteins, is of vital significance to overcome the devastating disease. Thus, we undertake an emerging immunoinformatics approach in order to design an effective, safe vaccine against Merkel Cell Polyomavirus that will protect humans against this devastating form of cancer.